Start your NGS cancer research today with the SureMASTR BRCA solutions!


SureMASTR BRCA Screen is the ideal solution to start your next-generation sequencing (NGS) testing for onco-genetics today. NGS is the go-to technology in onco-genetics. NGS allows you to provide fast, accurate and detailed results. SureMASTR BRCA Screen is an amplicon-based assay complete with easy to use data analysis software that identifies variants in four important genes related to breast- and ovarian cancers. It is easy to implement, reliable and fast. Thanks to the SureMASTR onboarding program, your lab will be up and running in no time!
For Research Use Only. Not for use in diagnostic procedures.
Download the interview with the BRCA Screen designer
SureMASTR BRCA Screen
SureMASTR BRCA Screen
SureMASTR BRCA screen, in combination with the MASTR Reporter data analysis software, is a molecular research solution for detection of variants in BRCA1, BRCA2, CHEK2, and PALB2. The solution suited for both germline and somatic use. The unique single primer-pool workflow requires low amount of input DNA and improves the quality of your results. The dedicated MASTR Reporter software, ensures the correct analysis of results and enables you to monitor and trace the quality of your results down to the smallest detail yourself.
SureMASTR BRCA Screen’s proven performance
The SureMASTR BRCA Screen has a high uniformity of amplification (0.2x mean coverage) on blood-derived DNA (germline) samples: 99.20 % (Illumina MiSeq) and on FFPE-derived DNA (somatic) samples: > 93.60 % (Illumina MiSeq, NextSeq and MiniSeq platforms). In addition, the on target read counts are > 97.45 % for blood-derived DNA (germline) samples and > 95.79 % for FFPE-derived DNA (somatic) samples.
How to start NGS Cancer research in your lab today?
Agilent makes sure you get off to a good start with Next-Generation Sequencing. The Onboarding Program helps you implement NGS in your laboratory step by step, from selecting the right equipment and software to supporting the validation of the first test runs and the training of your staff. Agilent does not stop until everything is running smoothly. Once your lab is ready to go, Agilent provides you with all the support you need to have a smooth and continuous day-to-day business. Experts are always available to help you solve any problem and improve your performance – by phone, by email or at your site.
Contact Agilent for more information!
SureMASTR BRCA Solutions
Agilent is a strong and reliable NGS player in the field of BRCA-testing. The robust SureMASTR catalog offer easy-to-use and reliable solutions for every BRCA question, whether it’s a germline or somatic application.
Find out more here
Agilent’s Oncology solutions
Is SureMASTR BRCA Screen not the solution you are looking for? Don’t worry, Agilent has built an extensive cancer portfolio based on its longtime knowledge of NGS. Agilent offers other catalog and custom NGS gene panels, analysis software, and automation systems
Discover it here
MASTR Reporter for data analysis
The quality of NGS results depends on a wide range of factors, from the quality of the initial sample to the way results are interpreted. MASTR Reporter for SureMASTR assays was developed with exactly this in mind.

Za odpiranje dokumenta
kliknite tukaj …

Comments are closed